Abstract:OBJECTIVE:To investigate the apoptosis and Fas (CD95) expression of T lymphocytes from the peripheral blood and peritoneal fluid of the patients with ovarian cancer and their relationship with CA125. METHODS:Apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes were assessed by flow cytometry. Peripheral blood samples were obtained from the following objects respectively: patients with stage III - IV ovarian cancer (n = 18) before and after treatment, patients with stage I - II ovarian cancer (n = 15), patients with benign ovarian tumor (n = 18), patients with Krukenberg tumor (n = 6) and normal control (n = 20). Peritoneal fluids were obtained from all the patients with ovarian cancer, Krukenberg tumor and ten patients with benign ovarian tumor. Level of serum CA125 of the patients with ovarian cancer was assessed. RESULTS:In the patients with stage III - IV ovarian cancer, the apoptosis level of the peripheral blood T lymphocytes was 5.55 (3.57 - 9.62)%, significantly higher than those from the patients with stage I - II ovarian cancer, patients with benign ovarian tumor, controls (P < 0.008 in all instances) and the patients with stage III - IV ovarian cancer after treatment (P < 0.05). The intensity of Fas expression of the peripheral blood T lymphocytes from the patients with stage III - IV ovarian cancer was 51 +/- 10, significantly higher than that from controls (P < 0.05). In peritoneal fluid, the apoptosis rates of T lymphocytes, positive rate and intensity of Fas expression on T lymphocytes from patients with stage I - II and stage III - IV ovarian cancer were 17.41 (7.06 - 24.56)%, (57 +/- 16)%, (55 +/- 11)% and 34.06 (17.03 - 44.65)%, (66 +/- 12)%, (70 +/- 24)%, respectively, increased significantly compared with those from patients with benign ovarian tumor, which were 0.78 (0.67 - 1.44)%, (37 +/- 6)%, 43 +/- 6, respectively (P < 0.01 in all instances). The apoptosis level and positive rate of Fas expression on peritoneal fluid T lymphocytes from patients with stage III - IV ovarian cancer were significantly higher than those from patients with Krukenberg tumor (P < 0.01). There was a positive correlation between the serum CA125 level and the apoptosis level of peritoneal fluid T cell in the patients with stage I - II ovarian cancer (r = 0.77, P = 0.009). For ovarian cancer, the apoptosis level of peritoneal fluid T lymphocytes from patients with the serum CA125 > 500 KU/L was higher than that from the patients with the serum CA125 < or = 500 KU/L (P = 0.009). CONCLUSIONS:(1) Extraordinarily increased apoptosis of T cells may play an important role in the development of systemic and celiac immunodeficiency in the patients with ovarian cancer. In contrast with the patients with Krukenberg tumor, the patients with advanced ovarian cancer hare higher percentage of apoptotic peritoneal fluid T lymphocytes, which shows the particularity of local immunity defect. (2) For the patients with ovarian cancer, efficient treatment can decrease the percentage of apoptotic peripheral blood T lymphocytes. (3) The increased positive rate and intensity of Fas expression on peritoneal fluid T lymphocytes stressed the significance of Fas interference in the treatment of ovarian cancer. (4) Level of serum CA125 can reflect the celiac immunity defection in patients with ovarian cancer.

Expression and Significance of Focal Adhesion Kinase in Ovarian Cancer

Expression of Focal Adhesion Kinase in Carcinomas and its Clinic Signification

Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Focal Adhesion Kinase Expression in Ovarian Endometriosis

Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis

Clinical significance of expression and phosphorylation of FAK in human osteosarcoma

Expression Of Fap Is Correlated With Clinical Prognosis In Ovarian Cancer Patients

Prognostic Value Of Focal Adhesion Kinase (Fak) In Human Solid Carcinomas: A Meta-Analysis

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

Focal Adhesion Kinase Overexpression and Its Impact on Human Osteosarcoma.

Focal adhesion kinase overexpression in endometrial neoplasia

Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma

Clinical Significance Of Ngal And Mmp-9 Protein Expression In Epithelial Ovarian Cancers

VEGF, VEGFRs Expressions and Activated STATs in Ovarian Epithelial Carcinoma

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

Study of Apoptosis and Fas Expression of Peritoneal Fluid and Peripheral Blood T Lymphocytes in Patients with Epithelial Ovarian Cancer and Their Relationship with CA125

Expression and Prognostic Significance of Focal Adhesion Kinase in Hepatocellular Carcinoma.

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

The Comparison of Expression of Focal Adhesion Kinase and Integrin Α5, Β1 Subunits in Gastric Carcinomas and Its Clinical Implication

Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.